← EXELIXIS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $191.5m |
$452.5m
+136.34%
|
$853.8m
+88.70%
|
$967.8m
+13.35%
|
$967.8m
0.00%
|
$1.4b
+48.28%
|
$1.6b
+12.27%
|
$1.8b
+13.60%
|
$2.2b
+18.49%
|
$2.3b
+6.98%
|
$2.4b
+4.99%
|
|
| Cost of Revenue | $6.6m |
$15.1m
+129.95%
|
$26.3m
+74.88%
|
$33.1m
+25.61%
|
$33.1m
0.00%
|
$52.9m
+59.75%
|
$57.9m
+9.52%
|
$72.5m
+25.28%
|
$76.2m
+5.06%
|
$83.7m
+9.82%
|
$85.7m
+2.35%
|
|
| Gross Profit (Calculated) | $184.9m |
$437.4m
+136.56%
|
$827.5m
+89.18%
|
$934.7m
+12.96%
|
$934.7m
0.00%
|
$1.4b
+47.87%
|
$1.6b
+12.38%
|
$1.8b
+13.17%
|
$2.1b
+19.05%
|
$2.2b
+6.88%
|
— | |
| Research and Development Expense | $96.0m | $112.2m | $182.3m | $337.0m | — | $693.7m | $891.8m | $1.0b | $910.4m | $825.0m | $824.3m | |
| Selling, General and Administrative Expense | $116.1m | $159.4m | $206.4m | $228.2m | $228.2m | $401.7m | $459.9m | $542.7m | $492.1m | $518.7m | $533.9m | |
| Operating Expenses | $219.6m | $286.6m | $415.0m | $598.3m | — | — | — | — | — | — | $1.4b | |
| Operating Income (Loss) | ($28.1m) |
$165.9m
+689.92%
|
$438.9m
+164.51%
|
$369.5m
-15.81%
|
$369.5m
0.00%
|
$286.7m
-22.41%
|
$201.5m
-29.71%
|
$170.9m
-15.19%
|
$604.6m
+253.82%
|
$872.2m
+44.26%
|
$992.0m
+13.74%
|
|
| Interest Expense | $33.1m | $8.7m | $0 | $0 | — | — | — | — | — | — | $0 | |
| Interest Income, Other | — | $4.9m | $12.8m | $28.0m | — | $7.7m | $33.1m | $86.5m | $77.2m | $69.2m | $63.7m | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($200k) | ($200k) | — | — | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | $4.9m | ($3.5m) | $397k | $680k | — | ($184k) | ($197k) | $93k | ($133k) | ($198k) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($70.2m) | $158.6m | — | — | — | — | — | — | — | — | $1.0b | |
| Current Income Tax Expense (Benefit) | $0 | $4.3m | $6.1m | $6.1m | — | $16.6m | $112.4m | $183.0m | $219.8m | $32.4m | $174.8m | |
| Income Tax Expense (Benefit) | $0 | $4.3m | ($238.0m) | $77.1m | — | $63.1m | $52.1m | $49.8m | $160.4m | $158.6m | $174.8m | |
| Net Income (Loss) Attributable to Parent | ($70.2m) |
$154.2m
+319.63%
|
$690.1m
+347.44%
|
$321.0m
-53.48%
|
$321.0m
0.00%
|
$231.1m
-28.02%
|
$182.3m
-21.11%
|
$207.8m
+13.98%
|
$521.3m
+150.89%
|
$782.6m
+50.13%
|
$860.6m
+9.97%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | ($70.2m) |
$153.9m
+319.11%
|
$690.1m
+348.51%
|
$321.0m
-53.48%
|
$321.0m
0.00%
|
$111.8m
-65.18%
|
$182.3m
+63.07%
|
$207.8m
+13.98%
|
— | $521.3m |
$860.6m
+65.10%
|
|
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | $367k | $0 | $0 | — | — | — | — | — | — | — | |
| Earnings Per Share, Basic | ($0.28) | $0.52 | $2.32 | $1.06 | $1.06 | $0.73 | $0.57 | $0.65 | $1.80 | $2.88 | $3.29 | |
| Earnings Per Share, Diluted | ($0.28) | $0.49 | $2.21 | $1.02 | $1.02 | $0.72 | $0.56 | $0.65 | $1.76 | $2.78 | $3.18 | |
| Weighted Average Number of Shares Outstanding, Basic | — | 293.6m | 297.9m | 302.6m | — | 314.9m | 321.5m | 318.2m | 290.0m | 271.6m | 261.0m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | 312.0m | 312.8m | 315.0m | — | 322.4m | 324.6m | 321.5m | 296.1m | 281.9m | 270.5m | |
| Additional Financial Items | ||||||||||||
| Cost, Depreciation and Amortization | — | — | — | — | — | — | — | — | $28.8m | $29.1m | — | |
| Costs and Expenses | — | — | — | — | — | $1.1b | $1.4b | $1.7b | $1.6b | $1.4b | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | — | $0 | $0 | $0 | $0 | $0 | $0 | |
| Income (Loss) Attributable to Parent, before Tax | — | — | — | — | — | $294.2m | $234.4m | $257.5m | $681.6m | $941.2m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.